BioPharma BoardRoom Book a theme

Editorial Calendar 2027

Leading the Reset: capital, science and sovereignty in global biopharma

Twelve monthly themes. Each one carries a cover story, three features, a BoardRoom Conversation, a data desk and a regional lens across North America, Europe, Asia and Oceania, with a ready-made sponsorship opportunity attached.

12monthly themes
4signature franchises
1.09M+average monthly users
449K+newsletter subscribers

How to read the calendar

One theme a month, planned around the moments the industry already watches.

Themes line up with the year's big market moments, from the J.P. Morgan Healthcare Conference in January to BIO International in June and CPHI Worldwide in the autumn. Brands that sponsor a theme sit next to the editorial conversation their buyers are already reading.

Inside every month

  1. Cover focusThe lead story that frames the month
  2. FeaturesThree deep dives on the theme
  3. ConversationExecutive interview with the leaders driving it
  4. Data deskA tracker, map or ranking built by our team
  5. Regional lensHow the theme plays out market by market
  6. SponsorshipWebinar, white paper, video or syndication slot

Show

12 themes

January 2027 · Q1

The 2027 Boardroom Agenda

Cover focusThe CEO Outlook 2027: capital discipline, tariffs and the patent cliff

Features

  • Where biopharma capital will flow in 2027
  • The loss-of-exclusivity countdown: lifecycle, biosimilars and BD responses
  • Tariffs, onshoring and the new cost of making medicines
BoardRoom Conversation
CEOs and CFOs on their 2027 operating plans
Data desk
BoardRoom Executive Outlook Survey 2027
Market moment
J.P. Morgan Healthcare Conference

Regional lens

US policy resetEU pharma legislationJapan and Korea growth strategiesAustralia's trial momentum

Ideal for advertisers in

CROs, CDMOs, consultancies, investment banks

Sponsor opportunityOutlook webinar partner, survey report sponsor
Materials by20 Dec 2026

February 2027 · Q1

Supply Chain Sovereignty

Cover focusMade where? Biopharma's new manufacturing map

Features

  • China plus one: India, Singapore and Korea as supply hubs
  • Supplier due diligence under new US biotech sourcing rules
  • Critical medicines, API security and cold chain resilience
BoardRoom Conversation
Chief Supply Chain Officers on dual sourcing
Data desk
Global Manufacturing Investment Tracker
Market moment
Q1 capex and sourcing decisions

Regional lens

US onshoring commitmentsEU critical medicines agendaAsian CDMO corridorsOceania sovereign vaccine capacity

Ideal for advertisers in

CDMOs, logistics, API suppliers, trade agencies

Sponsor opportunityCDMO white paper, supply chain content syndication
Materials by20 Jan 2027

March 2027 · Q1

Oncology Next

Cover focusADCs, radiopharma and bispecifics: the next oncology arms race

Features

  • Radioligand therapy: isotopes, sites and logistics
  • ADC manufacturing and the CDMO capacity race
  • Precision oncology and companion diagnostics
BoardRoom Conversation
Heads of oncology R&D
Data desk
Oncology Deal and Pipeline Watchlist
Market moment
Run-up to AACR Annual Meeting

Regional lens

US approvalsEU joint clinical assessments for oncologyChina-origin ADC licensingAustralia radiopharma

Ideal for advertisers in

ADC and radiopharma CDMOs, diagnostics, CROs

Sponsor opportunityOncology webinar, gated playbook
Materials by20 Feb 2027

April 2027 · Q2

AI at Work in R&D

Cover focusFrom pilots to pipelines: the AI-native biopharma

Features

  • Agentic AI in discovery and clinical operations
  • Data foundations, lab automation and digital twins
  • Regulating AI: FDA, EMA and Asian regulators compared
BoardRoom Conversation
Chief Data and Digital Officers
Data desk
AI-Discovered Molecules in the Clinic Tracker
Market moment
Q2 digital budgets

Regional lens

US AI platformsUK and EU AI rulesSingapore, Japan and Korea AI hubsChina AI biotech

Ideal for advertisers in

AI and software platforms, lab automation, cloud

Sponsor opportunityExplainer video series, AI readiness assessment
Materials by20 Mar 2027

May 2027 · Q2

The Metabolic Economy

Cover focusBeyond GLP-1: obesity, cardiometabolic disease and the next blockbuster wave

Features

  • Oral and next-generation incretins
  • Scaling peptide synthesis and fill-finish capacity
  • Payers, access and long-term outcomes data
BoardRoom Conversation
Cardiometabolic franchise leaders
Data desk
Obesity Pipeline Map 2027
Market moment
ADA Scientific Sessions run-up

Regional lens

US coverage debatesEuropean reimbursementgeneric entrants in India and ChinaOceania prevalence and access

Ideal for advertisers in

Peptide CDMOs, fill-finish, devices, CROs

Sponsor opportunityPeptide manufacturing white paper, webinar
Materials by20 Apr 2027

June 2027 · Q2

Deals, Licensing & the Asia Source

Cover focusThe BD playbook 2027: who buys, who licenses, who leads

Features

  • Asia-origin assets and Western licensing deals
  • Mid-year M&A and venture review
  • The IPO window and crossover capital
BoardRoom Conversation
Heads of BD and leading investors
Data desk
H1 2027 DealWatch
Market moment
BIO International Convention

Regional lens

US big pharma buyersEuropean mid-capsChina, Korea and Japan out-licensingAustralian biotech listings

Ideal for advertisers in

Law firms, banks, investors, partnering platforms

Sponsor opportunityDealWatch report partner, partnering webinar
Materials by20 May 2027

July 2027 · Q3

Cell, Gene & In Vivo Frontiers

Cover focusMaking advanced therapies affordable: in vivo, allogeneic and automated

Features

  • In vivo CAR-T and gene editing
  • Automation and point-of-care manufacturing
  • Outcomes-based payment models
BoardRoom Conversation
CGT founders and Chief Medical Officers
Data desk
CGT Approvals and Capacity Tracker
Market moment
BIO Asia-Taiwan and mid-year planning

Regional lens

FDAEU ATMP rulesJapan's conditional pathwayCAR-T in China, Korea and IndiaAustralia

Ideal for advertisers in

Viral vector CDMOs, tools, automation, logistics

Sponsor opportunityCGT playbook, gated video
Materials by20 Jun 2027

August 2027 · Q3

Clinical Trials Reinvented

Cover focusFaster, fairer, more global: the new clinical trial map

Features

  • Asia-Pacific as a first-choice trial destination
  • Decentralised and hybrid trial models
  • Real-world evidence and diversity in enrolment
BoardRoom Conversation
Heads of clinical operations and CRO leaders
Data desk
APAC Clinical Trial Landscape
Market moment
H2 study start-up planning

Regional lens

US FDA guidanceEU Clinical Trials RegulationANZ early phaseJapan, Korea, China, India, Singapore sites

Ideal for advertisers in

CROs, site networks, eClinical, RWE providers

Sponsor opportunityCRO content syndication, webinar
Materials by20 Jul 2027

September 2027 · Q3

Biomanufacturing 4.0

Cover focusContinuous, connected, compliant: the smart plant

Features

  • Continuous processing and PAT
  • Single-use, sustainability, water and energy
  • Data integrity, MES and cyber resilience
BoardRoom Conversation
CDMO chiefs and plant heads
Data desk
Global CDMO Capacity Outlook
Market moment
Run-up to CPHI Worldwide

Regional lens

US and EU plant investmentsIndia, Singapore and Korea biomanufacturingMiddle East localisation

Ideal for advertisers in

Bioprocess equipment, single-use, MES, automation

Sponsor opportunityTools and equipment white papers, explainer video
Materials by20 Aug 2027

October 2027 · Q4

Access, Pricing & Value

Cover focusWho pays for innovation? Pricing and access in a reset world

Features

  • US pricing reform and international reference pressure
  • EU HTA joint clinical assessments in practice
  • Value-based pricing and reimbursement in Asia
BoardRoom Conversation
Market access and policy leaders
Data desk
Market Access Scorecard by Country
Market moment
CPHI Worldwide

Regional lens

US pricingEU HTAJapan price revisionsChina VBP and NRDLAustralia PBS

Ideal for advertisers in

HEOR consultancies, market access agencies, data

Sponsor opportunityMarket access webinar, HEOR white paper
Materials by20 Sep 2027

November 2027 · Q4

Immunology, Vaccines & Global Health

Cover focusImmunology, vaccines and AMR: the protection agenda

Features

  • I&I pipelines and bispecifics
  • Next-generation vaccine platforms and confidence
  • AMR incentives and pandemic preparedness financing
BoardRoom Conversation
Global health and vaccine leaders
Data desk
Vaccine and AMR Pipeline Watch
Market moment
BIO-Europe

Regional lens

US and European preparednessAsian vaccine hubsAfrican manufacturingOceania mRNA capacity

Ideal for advertisers in

Vaccine CDMOs, cold chain, diagnostics, public health

Sponsor opportunityVaccine manufacturing webinar, roundtable
Materials by20 Oct 2027

December 2027 · Q4

The BoardRoom Leadership Index 2027

Cover focusThe Leadership Index 2027: who moved the industry

Features

  • CEO scorecard: visionaries and disruptors
  • Top 10 breakthroughs and deals of 2027
  • 2028 outlook: governance, boards and AI
BoardRoom Conversation
Board chairs on governance
Data desk
BoardRoom Leadership Index rankings
Market moment
Year-end planning

Regional lens

Cross-regional benchmarks across North America, Europe, Asia, Oceania and MEA

Ideal for advertisers in

Executive search, advisory, investors, all brands

Signature franchises

Four flagship properties, open for partners

JANUARY

Executive Outlook Survey

A pulse of biopharma leaders on capital, tariffs, pricing and hiring for the year ahead.

JUNE

H1 DealWatch

A mid-year review of licensing, M&A and venture flows across every region.

MONTHLY

BoardRoom Data Desk

Trackers on AI molecules, CGT capacity, obesity pipelines, CDMO capacity and more.

DECEMBER

Leadership Index 2027

Our annual ranking of the leaders who moved the industry, with category partners.

Book a theme

Put your brand inside the right month.

Tell us which themes fit your 2027 launches. We will send a sponsorship plan with lead forecasts for each slot. Materials for each month are due by the 20th of the preceding month.

Advertising and sponsorshipdigital@biopharmaboardroom.com
Editorial topics and interview requestseditor@biopharmaboardroom.com
Websitewww.biopharmaboardroom.com
Visit
BioPharma BoardRoom | Editorial Calendar 2027Themes may be refined as the year develops.